ClinicalTrials.Veeva

Menu

DOREFA (Retinal Detachment: Function and Anatomy)

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Completed

Conditions

Retinal Detachment

Treatments

Procedure: OCT Spectralis
Procedure: microperimetry

Study type

Interventional

Funder types

Other

Identifiers

NCT01767038
Creuzot-Garcher PHRC N 2010

Details and patient eligibility

About

Patients with retinal detachment do not always recover good visual function. Sometimes simple causes are responsible. Other causes can only be discovered thanks to high-resolution imaging provided by the latest generation of OCT.

This study is possible thanks to surgical teams who have a strong recruitment potential, with the experience of a joint project in 2007-2008 (PHRC national - Etude DOREMY, Etude FRIENDS) to define more strict intervention criteria. The principal objective of this study is to better define with regard to time:

  • The onset of surgically curable or transient macular affections, and losses in visual acuity that can be qualified as "explained"
  • But above all to better understand the relationships between anatomical analyses obtained using OCT and autofluorescence and functional analysis using visual acuity and microperimetry.
  • In the near future, two techniques (OCT and microperimetry) will certainly become essential tools in the evaluation of macular function. Better understanding of these relationships is the first necessary step in any study concerning the therapeutic prevention of retinal lesions related to retinal detachment: This study will make it possible to define criteria for the evaluation of anatomical and functional recovery, their relationship with each other and finally their evolution over time. This is an essential first phase before possible therapies can be evaluated.

Enrollment

202 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who have provided written informed consent
  • Retinal detachment with pre-operative raised macula, re-attached during a surgical intervention with one month of follow-up
  • Patients undergoing surgery as the first-line treatment (ab extern surgery or gas vitrectomy)
  • Patients who accept to be followed for at least 12 months at the investigating center.

Exclusion criteria

  • Persons who are not registered with social security agency
  • Macular affections pre-existent to the DR
  • Retinal detachment requiring several interventions to obtain a reapplication
  • Lazy eye with pre-operative
  • Brightness of the circles not allowing the realization of the examinations

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems